DexTech Medical AB (XSAT:DEX) Notes Receivable: kr0.00 Mil (As of Mar. 2026)


XSAT:DEX DexTech Medical AB XSAT:DEX
17 GF Score
Price kr10.20
! 3 Warning Signs
View Full Analysis

What is DexTech Medical AB Notes Receivable?

DexTech Medical AB XSAT:DEX -0.49% 17 Notes Receivable is kr0.00 Mil as of Mar. 2026. GuruFocus rates XSAT:DEX with a GF Score™ of 17/100. The stock has 3 warning signs investors should review.

DexTech Medical AB's Notes Receivable for the quarter that ended in Mar. 2026 was kr0.00 Mil.

DexTech Medical AB Notes Receivable Related Terms

DexTech Medical AB Notes Receivable Historical Data

* Premium members only.

The historical data trend for DexTech Medical AB's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexTech Medical AB Notes Receivable Chart

DexTech Medical AB Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DexTech Medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSAT:DEX
17GF Score
DexTech Medical AB XSAT:DEX
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DexTech Medical AB Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of kr0.00 Mil mean?
DexTech Medical AB (XSAT:DEX) has a Notes Receivable of kr0.00 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on DexTech Medical AB and its competitors.
Is DexTech Medical AB's Notes Receivable too high?
DexTech Medical AB's current Notes Receivable is kr0.00 Mil. Overall, DexTech Medical AB has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does DexTech Medical AB's Notes Receivable compare to VRTX and REGN?
DexTech Medical AB's Notes Receivable of kr0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on DexTech Medical AB and its competitors. DexTech Medical AB's current Notes Receivable is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexTech Medical AB stock overvalued right now?
DexTech Medical AB (XSAT:DEX) has a current Notes Receivable of kr0.00 Mil. The current Notes Receivable is kr0.00 Mil. DexTech Medical AB's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For DexTech Medical AB (XSAT:DEX), the current Notes Receivable is kr0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DexTech Medical AB Business Description

Address Dag Hammarskjolds Vag 34A, Uppsala, SWE, 752 37
DexTech Medical AB is a Swedish research company specializing in drug development for urological oncology, with a prominent focus on prostate cancer. The company develops drug candidates using a proprietary carbohydrate platform, advancing treatments aimed at castration-resistant prostate cancer and related conditions. Its operations center on research, development, and licensing of these drug candidates. It has four drug candidates: OsteoDex, SomaDex, PSMA-binding conjugates, and GuaDex.
17GF Score

Get the complete analysis for XSAT:DEX

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr10.20
Price